CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+5.62%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$16.5B
AUM Growth
+$861M
(+5.5%)
Cap. Flow
-$376M
Cap. Flow
% of AUM
-2.28%
Top 10 Holdings %
Top 10 Hldgs %
30.08%
Holding
747
New
44
Increased
335
Reduced
212
Closed
49
Top Buys
| 1 |
Eli Lilly
LLY
|
$68M |
| 2 |
Qualcomm
QCOM
|
$56.3M |
| 3 |
Nu Holdings
NU
|
$53.7M |
| 4 |
Amazon
AMZN
|
$49M |
| 5 |
Banco Macro
BMA
|
$43.2M |
Top Sells
| 1 |
Vipshop
VIPS
|
$599M |
| 2 |
Apple
AAPL
|
$46.1M |
| 3 |
Adobe
ADBE
|
$41.4M |
| 4 |
Starbucks
SBUX
|
$30M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$28.3M |
Sector Composition
| 1 | Technology | 33% |
| 2 | Healthcare | 27.47% |
| 3 | Financials | 9.69% |
| 4 | Consumer Discretionary | 7.72% |
| 5 | Industrials | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Moody's
MCO
$91B
| $16.4M | 0.1% |
39,016
+1,311
| +3% | +$552K |
|
202
MasTec
MTZ
$13.9B
| $16.4M | 0.1% |
153,010
-58,331
| -28% | -$6.24M |
|
|
DFS
203
DELISTED
Discover Financial Services
DFS
| $16.3M | 0.1% |
124,557
+96,920
| +351% | +$12.7M |
|
204
TopBuild
BLD
$12.2B
| $16.3M | 0.1% |
42,187
-4,860
| -10% | -$1.87M |
|
205
Arvinas
ARVN
$583M
| $16.2M | 0.1% |
610,458
+147,904
| +32% | +$3.94M |
|
206
Exelixis
EXEL
$10.1B
| $15.9M | 0.1% |
707,635
-47,842
| -6% | -$1.07M |
|
|
BCYC
207
Bicycle Therapeutics
BCYC
$485M
| $15.4M | 0.09% |
759,180
-130,078
| -15% | -$2.63M |
|
208
Electronic Arts
EA
$42B
| $15M | 0.09% |
107,545
-30,299
| -22% | -$4.22M |
|
209
Graphic Packaging
GPK
$6.24B
| $14.8M | 0.09% |
563,964
-36,344
| -6% | -$953K |
|
210
Oracle
ORCL
$670B
| $14.6M | 0.09% |
103,114
+7,708
| +8% | +$1.09M |
|
211
Veracyte
VCYT
$2.55B
| $14.5M | 0.09% |
670,937
| – | – |
|
212
Truist Financial
TFC
$59.3B
| $14.4M | 0.09% |
371,817
+264,181
| +245% | +$10.3M |
|
213
Verizon
VZ
$183B
| $14.4M | 0.09% |
348,749
-305,849
| -47% | -$12.6M |
|
214
Target
TGT
$41.6B
| $14.2M | 0.09% |
95,932
+15,671
| +20% | +$2.32M |
|
215
Agios Pharmaceuticals
AGIO
$2.12B
| $13.9M | 0.08% |
+322,882
| New | +$13.9M |
|
216
Okta
OKTA
$16.3B
| $13.9M | 0.08% |
148,506
+72,828
| +96% | +$6.82M |
|
217
IDEX
IEX
$12.4B
| $13.8M | 0.08% |
68,526
+9,886
| +17% | +$1.99M |
|
218
Arista Networks
ANET
$176B
| $13.4M | 0.08% |
153,388
+50,640
| +49% | +$4.44M |
|
219
Quest Diagnostics
DGX
$20.4B
| $13.4M | 0.08% |
64,863
+5,375
| +9% | +$1.11M |
|
220
Marsh & McLennan
MMC
$100B
| $13.3M | 0.08% |
63,355
+3,800
| +6% | +$801K |
|
221
General Mills
GIS
$26.8B
| $13.3M | 0.08% |
98,725
+158
| +0.2% | +$21.3K |
|
222
Lear
LEA
$6B
| $13.3M | 0.08% |
116,261
+34,582
| +42% | +$3.95M |
|
223
Kimberly-Clark
KMB
$43.1B
| $13.1M | 0.08% |
95,130
-1,691
| -2% | -$234K |
|
224
DexCom
DXCM
$30.6B
| $13.1M | 0.08% |
115,749
-58,167
| -33% | -$6.59M |
|
225
Roper Technologies
ROP
$56.3B
| $13.1M | 0.08% |
23,263
+3,487
| +18% | +$1.97M |
|